Your browser doesn't support javascript.
loading
Safety, efficacy and drug survival of biologics and biosimilars for moderate-to-severe plaque psoriasis.
Egeberg, A; Ottosen, M B; Gniadecki, R; Broesby-Olsen, S; Dam, T N; Bryld, L E; Rasmussen, M K; Skov, L.
Affiliation
  • Egeberg A; Department of Dermatology and Allergy, Herlev and Gentofte Hospital, University of Copenhagen, Hellerup, Denmark.
  • Ottosen MB; Department of Dermatology and Allergy, Herlev and Gentofte Hospital, University of Copenhagen, Hellerup, Denmark.
  • Gniadecki R; Department of Dermatology, Bispebjerg Hospital, Copenhagen, Denmark.
  • Broesby-Olsen S; Department of Dermatology and Allergy Centre, Odense University Hospital, Odense, Denmark.
  • Dam TN; Skin Clinic, Nykøbing Falster, Denmark.
  • Bryld LE; Department of Dermatology, Roskilde Hospital, Roskilde, Denmark.
  • Rasmussen MK; Department of Dermatology, Aarhus University Hospital, Aarhus, Denmark.
  • Skov L; Department of Dermatology and Allergy, Herlev and Gentofte Hospital, University of Copenhagen, Hellerup, Denmark.
Br J Dermatol ; 178(2): 509-519, 2018 02.
Article in En | MEDLINE | ID: mdl-29094341
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Psoriasis / Biological Factors / Dermatologic Agents / Biosimilar Pharmaceuticals Limits: Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: Br J Dermatol Year: 2018 Document type: Article Affiliation country: Denmark Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Psoriasis / Biological Factors / Dermatologic Agents / Biosimilar Pharmaceuticals Limits: Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: Br J Dermatol Year: 2018 Document type: Article Affiliation country: Denmark Country of publication: United kingdom